Medi Caps

{
  "main_header": {
    "sid": 723558,
    "name": "Medi Caps",
    "stock_name": "Medi Caps",
    "full_name": "Medi Caps Ltd",
    "name_url": "stocks-analysis/medi-caps",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "25.37",
    "chg": 1.68,
    "chgp": "7.09%",
    "dir": 1,
    "prev_price": "23.69",
    "mcapval": "32.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 523144,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE442D01010",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "45 ",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medi-caps-723558-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Medi Caps Ltd Stock Falls to 52-Week Low of Rs.21 Amidst Continued Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-ltd-stock-falls-to-52-week-low-of-rs21-amidst-continued-weakness-3885308",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MediCapsLtd_priceRelatedfactors_3885308.png",
        "date": "2026-03-11 15:06:30",
        "description": "Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.21 today, marking a significant decline in its stock price amid a broader market downturn and persistent company-specific headwinds."
      },
      {
        "title": "Medi Caps Ltd Stock Falls to 52-Week Low of Rs.21.02 Amidst Continued Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-ltd-stock-falls-to-52-week-low-of-rs2102-amidst-continued-financial-struggles-3844375",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MediCapsLtd_priceRelatedfactors_3844375.png",
        "date": "2026-02-17 10:49:01",
        "description": "Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.21.02 today, marking a significant decline in its stock price amid ongoing financial difficulties and subdued operational performance."
      },
      {
        "title": "Medi Caps Ltd Stock Falls to 52-Week Low of Rs.21.56 Amidst Continued Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-ltd-stock-falls-to-52-week-low-of-rs2156-amidst-continued-weakness-3842589",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MediCapsLtd_priceRelatedfactors_3842589.png",
        "date": "2026-02-16 12:17:51",
        "description": "Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.21.56 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and benchmark indices, reflecting ongoing financial pressures and subdued market sentiment."
      },
      {
        "title": "Medi Caps Ltd Falls 8.84%: Four Key Factors Driving the Steep Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-ltd-falls-884-four-key-factors-driving-the-steep-decline-3839810",
        "imagepath": "",
        "date": "2026-02-14 15:10:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>09 Feb:</strong> Stock hits 52-week low of Rs.24 amid ongoing weakness</p>\n                    <p><strong>11 Feb:</strong> Q3 FY26 results reveal deepening losses</p>\n                    <p><strong>12 Feb:</strong> New 52-week low of Rs.22.99 recorded</p>\n                    <p><strong>13 Feb:</strong> Further decline to 52-week low of Rs.22 amid continued downtrend</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.24.33</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.22.18</div><div..."
      },
      {
        "title": "Medi Caps Ltd Stock Falls to 52-Week Low of Rs.22 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-ltd-stock-falls-to-52-week-low-of-rs22-amidst-continued-downtrend-3837346",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MediCapsLtd_priceRelatedfactors_3837346.png",
        "date": "2026-02-13 10:53:40",
        "description": "Medi Caps Ltd, a company operating in the Pharmaceuticals & Biotechnology sector, has witnessed its stock price decline to a fresh 52-week low of Rs.22 today, marking a significant downturn amid a broader market environment that remains mixed. This new low reflects ongoing pressures on the company’s financial performance and market valuation."
      },
      {
        "title": "Are Medi Caps Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-medi-caps-ltd-latest-results-good-or-bad-3835827",
        "imagepath": "",
        "date": "2026-02-12 19:56:36",
        "description": "Medi Caps Ltd's latest financial results indicate a company facing significant operational challenges. In the quarter ended December 2025, the company reported net sales of ₹4.30 crores, reflecting a sequential improvement of 112.87% from the previous quarter. However, this increase is overshadowed by a year-on-year decline of 56.61%, highlighting persistent structural issues within its core capsule manufacturing business.\n\nThe company posted a net loss of ₹0.77 crores for the quarter, which represents a 62.44% deterioration compared to the same period last year. The operating margin was deeply negative at -24.71%, indicating ongoing operational inefficiencies and an inability to generate sustainable sales volumes. Furthermore, the return on equity has fallen to -4.84%, reflecting the company's struggles to provide returns on the capital employed.\n\nDespite the sequential revenue growth, the overall financia..."
      },
      {
        "title": "Medi Caps Ltd Stock Falls to 52-Week Low of Rs.22.99 Amidst Continued Weak Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-ltd-stock-falls-to-52-week-low-of-rs2299-amidst-continued-weak-performance-3834622",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MediCapsLtd_priceRelatedfactors_3834622.png",
        "date": "2026-02-12 09:52:51",
        "description": "Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.22.99 today, marking a significant decline in its stock price amid ongoing financial pressures and subdued market performance."
      },
      {
        "title": "Are Medi Caps Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-medi-caps-ltd-latest-results-good-or-bad-3833535",
        "imagepath": "",
        "date": "2026-02-11 19:46:20",
        "description": "Medi Caps Ltd's latest financial results for Q2 FY26 reveal significant operational challenges, characterized by a substantial net loss of ₹1.82 crores, a stark contrast to a profit of ₹0.31 crores in the same quarter last year. Revenue also saw a dramatic decline, falling to ₹2.02 crores, which represents a 75.63% decrease year-on-year and the lowest quarterly sales figure in recent history. This revenue drop indicates severe demand issues or operational disruptions within the company.\n\nThe company's operating margin was reported at a deeply negative 144.28%, highlighting severe operational inefficiencies and an inability to cover basic costs. Employee costs remained high, consuming over 90% of total revenue, which exacerbates the financial strain. The return on equity has also deteriorated, with a five-year average of just 2.03%, reflecting poor capital efficiency.\n\nSequentially, the results show a declin..."
      },
      {
        "title": "Medi Caps Q3 FY26: Losses Deepen as Revenue Struggles Continue",
        "link": "https://www.marketsmojo.com/news/result-analysis/medi-caps-q3-fy26-losses-deepen-as-revenue-struggles-continue-3833685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MediCaps_quaterlyResult_3833685.png",
        "date": "2026-02-11 18:34:28",
        "description": "Medi Caps Ltd., one of India's established manufacturers of empty hard gelatine capsules, posted a net loss of ₹0.77 crores in Q3 FY26, marking its third consecutive quarter of losses. The Madhya Pradesh-based pharmaceutical company, with a market capitalisation of ₹31.00 crores, continues to face severe operational headwinds as revenue declined 56.61% year-on-year to ₹4.30 crores during the quarter ended December 2025."
      }
    ],
    "total": 102,
    "sid": "723558",
    "stock_news_url": "https://www.marketsmojo.com/news/medi-caps-723558"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "The trading window shall remain close for the trading of the shares of the company from 01.04.2026 till the completion of 48 hours of declaration of audited financial results for the quarter and financial year end on 31.03.2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Feb-2026",
      "details": "Extract of un-audited standalone and consolidated financial results of the company for the quarter and nine month ended on 31.12.2025 published in Free press journal English edition and Choutha sansar Hindi edition dated 13.02.2026. copy of news paper attached.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Standalone & Consolidated Financial Results For The Quarter & Nine Month Ended 31.12.2025",
      "datetime": "11-Feb-2026",
      "details": "Submission of unaudited standalone & consolidated financial results for the quarter & nine month ended 31.12.2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Medi Caps Ltd has declared <strong>15%</strong> dividend, ex-date: 20 Sep 12",
          "dt": "2012-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Medi Caps Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Mar 13",
          "dt": "2013-03-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Medi Caps Ltd Stock Falls to 52-Week Low of Rs.21 Amidst Continued Weakness

2026-03-11 15:06:30

Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.21 today, marking a significant decline in its stock price amid a broader market downturn and persistent company-specific headwinds.

Read full news article

Medi Caps Ltd Stock Falls to 52-Week Low of Rs.21.02 Amidst Continued Financial Struggles

2026-02-17 10:49:01

Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.21.02 today, marking a significant decline in its stock price amid ongoing financial difficulties and subdued operational performance.

Read full news article

Medi Caps Ltd Stock Falls to 52-Week Low of Rs.21.56 Amidst Continued Weakness

2026-02-16 12:17:51

Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.21.56 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and benchmark indices, reflecting ongoing financial pressures and subdued market sentiment.

Read full news article

Medi Caps Ltd Falls 8.84%: Four Key Factors Driving the Steep Decline

2026-02-14 15:10:16

Key Events This Week

09 Feb: Stock hits 52-week low of Rs.24 amid ongoing weakness

11 Feb: Q3 FY26 results reveal deepening losses

12 Feb: New 52-week low of Rs.22.99 recorded

13 Feb: Further decline to 52-week low of Rs.22 amid continued downtrend

Week Open

Rs.24.33

Week Close

Rs.22.18

Read full news article

Medi Caps Ltd Stock Falls to 52-Week Low of Rs.22 Amidst Continued Downtrend

2026-02-13 10:53:40

Medi Caps Ltd, a company operating in the Pharmaceuticals & Biotechnology sector, has witnessed its stock price decline to a fresh 52-week low of Rs.22 today, marking a significant downturn amid a broader market environment that remains mixed. This new low reflects ongoing pressures on the company’s financial performance and market valuation.

Read full news article

Are Medi Caps Ltd latest results good or bad?

2026-02-12 19:56:36

Medi Caps Ltd's latest financial results indicate a company facing significant operational challenges. In the quarter ended December 2025, the company reported net sales of ₹4.30 crores, reflecting a sequential improvement of 112.87% from the previous quarter. However, this increase is overshadowed by a year-on-year decline of 56.61%, highlighting persistent structural issues within its core capsule manufacturing business. The company posted a net loss of ₹0.77 crores for the quarter, which represents a 62.44% deterioration compared to the same period last year. The operating margin was deeply negative at -24.71%, indicating ongoing operational inefficiencies and an inability to generate sustainable sales volumes. Furthermore, the return on equity has fallen to -4.84%, reflecting the company's struggles to provide returns on the capital employed. Despite the sequential revenue growth, the overall financia...

Read full news article

Medi Caps Ltd Stock Falls to 52-Week Low of Rs.22.99 Amidst Continued Weak Performance

2026-02-12 09:52:51

Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.22.99 today, marking a significant decline in its stock price amid ongoing financial pressures and subdued market performance.

Read full news article

Are Medi Caps Ltd latest results good or bad?

2026-02-11 19:46:20

Medi Caps Ltd's latest financial results for Q2 FY26 reveal significant operational challenges, characterized by a substantial net loss of ₹1.82 crores, a stark contrast to a profit of ₹0.31 crores in the same quarter last year. Revenue also saw a dramatic decline, falling to ₹2.02 crores, which represents a 75.63% decrease year-on-year and the lowest quarterly sales figure in recent history. This revenue drop indicates severe demand issues or operational disruptions within the company. The company's operating margin was reported at a deeply negative 144.28%, highlighting severe operational inefficiencies and an inability to cover basic costs. Employee costs remained high, consuming over 90% of total revenue, which exacerbates the financial strain. The return on equity has also deteriorated, with a five-year average of just 2.03%, reflecting poor capital efficiency. Sequentially, the results show a declin...

Read full news article

Medi Caps Q3 FY26: Losses Deepen as Revenue Struggles Continue

2026-02-11 18:34:28

Medi Caps Ltd., one of India's established manufacturers of empty hard gelatine capsules, posted a net loss of ₹0.77 crores in Q3 FY26, marking its third consecutive quarter of losses. The Madhya Pradesh-based pharmaceutical company, with a market capitalisation of ₹31.00 crores, continues to face severe operational headwinds as revenue declined 56.61% year-on-year to ₹4.30 crores during the quarter ended December 2025.

Read full news article

View All News